American Heart Journal
Volume 160, Issue 2 , Pages 264-271.e1 , August 2010

Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization

  • Husam M. Abdel-Qadir, MD

      Affiliations

    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Jack V. Tu, MD, PhD

      Affiliations

    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
    • Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Lingsong Yun, MSc

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
    • ,
  • Peter C. Austin, PhD

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
    • Dalla Lana School of Public Health, Toronto, Ontario, Canada
    • ,
  • Gary E. Newton, MD

      Affiliations

    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Division of Cardiology, University Health Network, Toronto, Ontario, Canada
    • ,
  • Douglas S. Lee, MD, PhD

      Affiliations

    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
    • Division of Cardiology, University Health Network, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Douglas S. Lee, MD, PhD, Institute for Clinical Evaluative Sciences, Rm G-106, 2075 Bayview Ave, Toronto, ON, Canada M4N 3M5.

Received 23 February 2010 ,Accepted 20 May 2010.

References 

  1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–e181
  2. Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003;24:464–474
  3. Chuen MJ, MacFadyen RJ. Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure. Am J Cardiol. 2006;98:1416–1417
  4. Felker GM, O'Connor CM, Braunwald E. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?. Circ Heart Fail. 2009;2:56–62
  5. Gupta S, Neyses L. Diuretic usage in heart failure: a continuing conundrum in 2005. Eur Heart J. 2005;26:644–649
  6. Weber KT. Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain. J Am Coll Cardiol. 2004;44:1308–1310
  7. Ahmed A, Young JB, Love TE, et al. A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure. Int J Cardiol. 2008;125:246–253
  8. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol. 2006;97:1759–1764
  9. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147:331–338
  10. Mehta RL, Pascual MT, Soroko S, et al. PICARD Study Group Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547–2553
  11. Sun WY, Reiser IW, Chou SY. Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure. Am J Kidney Dis. 2006;47:798–808
  12. Heidrich FE, Stergachis A, Gross KM. Diuretic drug use and the risk for hip fracture. Ann Intern Med. 1991;115:1–6
  13. Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated with loop diuretics. J Intern Med. 2006;259:117–124
  14. Cooper HA, Dries DL, Davis CE, et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation. 1999;100:1311–1315
  15. Tu JV, Donovan LR, Lee DS, et al. Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA. 2009;302:2330–2337
  16. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure. NEJM. 1971;285:1441–1446
  17. Lee DS, Austin PC, Stukel TA, et al. “Dose-dependent” impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med. 2009;122:162–169
  18. Levy AR, O'Brien BJ, Sellors C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10:67–71
  19. Hasselblad V, Gattis SW, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007;9:1064–1069
  20. Domanski M, Norman J, Pitt B, et al. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 2003;42:705–708
  21. Neuberg GW, Miller AB, O'Connor CM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J. 2002;144:31–38
  22. Rejnmark L, Vestergaard P, Heickendorff L, et al. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women. Eur J Clin Invest. 2001;31:764–772
  23. Rejnmark L, Vestergaard P, Heickendorff L, et al. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res. 2006;21:163–170
  24. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113:671–678
  25. McCurley JM, Hanlon SU, Wei SK, et al. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol. 2004;44:1301–1307
  26. Bayliss J, Norell M, Canepa-Anson R, et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987;57:17–22
  27. Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med. 1985;103:1–6
  28. van Kraaij DJ, Jansen RW, Sweep FC, et al. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. Eur J Heart Fail. 2003;5:47–53
  29. Salerno DM, Asinger RW, Elsperger J, et al. Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction. Am J Cardiol. 1987;59:84–88
  30. Waikar SS, Wald R, Chertow GM, et al. Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol. 2006;17:1688–1694

PII: S0002-8703(10)00438-2

doi: 10.1016/j.ahj.2010.05.032

American Heart Journal
Volume 160, Issue 2 , Pages 264-271.e1 , August 2010

Article Tools

* Image Usage & Resolution